Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM78B antisense RNA 1 (FAM78B-AS1) is a human long non-coding RNA (lncRNA) gene located antisense to the FAM78B coding gene and transcribed from the opposite DNA strand[1][6]. It is annotated in genome databases, with several transcript variants, but its biological function, regulatory role, involvement in disease, and therapeutic relevance have not been established in the literature. It is distinct from well-studied antisense RNAs such as FAM83A-AS1, and its name does not correspond to a protein, enzyme, or conventional drug target. FAM78B-AS1 currently represents a poorly characterized lncRNA, and is not considered a validated molecular target in translational research or drug development contexts[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM78B antisense RNA 1 (FAM78B-AS1).